Yes, prodrugs can cause toxicity if their conversion leads to the formation of harmful byproducts. The rate and extent of conversion, influenced by genetic variations in metabolic enzymes, can result in interindividual variability in drug response and toxicity. Furthermore, if a prodrug is metabolized too quickly, it may lead to acute toxicity, while slow metabolism might cause insufficient therapeutic effect or drug accumulation, potentially leading to chronic toxicity.
